Trending >

Treatment.com AI CEO Dr. Essam Hamza interview at Cantech 24

TRUE stock

Dr. Essam Hamza says all the pieces are in place.

The lifelong physician and technology entrepreneur is known to some Canadian investors as the founder of CloudMD. But he says Treatment.com AI (Treatment.com AI Stock Quote, Chart, News, Analysts, Financials CSE:TRUE) is taking the next great leap in healthcare technology.

“The one piece that was missing from that company is what Treatment has,” he said. “I was really excited at the end of last year to join Treatment.com AI as the CEO. “There are only a handful of companies around the world that have this type of technology. We think we have one of the better solutions, and it’s really transforming the way that healthcare is going to be delivered in the future.” Hamza says doctors in Canada are growing frustrated because for every five minutes they spend with a patient they are then spending twenty or thirty minutes on paperwork. The solution, he says, is right there is his company’s name.

“The solution,” Hamza told MacArthur, “is using AI tools to help triage and onboard patients in doing all the admin work for the practitioners so that there will be no more guessing on what the patient has, we will know based on diagnostic tools and precision medicine. There will be no more patients just showing up in a clinic or emergency room and we have no idea what they have or why they are there. The tools are there now and they’re only getting better.”

 

For the full interview, see below:

About The Author /

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.
insta twitter facebook

Comment

RELATED POSTS